Saad Harti, MBA
Founder, Chairman & CEO
Switzerland
Saad is Chairman and CEO of Legacy Healthcare, a company he founded in 2007. Prior to that he was founder and CEO of Altacare, a distributor of innovative healthcare products servicing 60 markets around the world. He served as Chief Financial Officer of HRA Pharma a fast-growing healthcare company with a focus on women’s health, contraception and compromised skin. He worked as a Director, audit & transactions for Arthur Anderson and began his career in medical marketing as an Assistant Product Manager for Glaxo SmithKline. Saad has an MBA from NEOMA Business School in France.

Bruce Patsner MD, JD
Medical
US
Bruce Patsner M.D. J.D. is a cancer surgeon, law Professor and former Senior Medical Officer at FDA with more than 15 years Pharma experience in clinical trial design, new prescription drug approval and pharmacovigilance, and regulation of drugs, devices, and biologics. While at FDA he was responsible for the approval of several new prescription drugs in women’s health and Oncology and reviewed more than 50 INDs. He is also a current member of the Editorial Board of the prestigious law journal Food and Drug Law.

Saad Harti
Founder & Chairman
Switzerland
Saad has started in the financial field, at Arthur Andersen.He later co-founded Altacare, a healthcare business development firm active in more than 50 markets. Saad has pioneered contraceptive-access programs in developing countries. Saad is the founder of Legacy and manages the company.

Alexandre Guichard
Clinical
Switzerland
Dr. Alexandre Guichard, PharmD, Ph D is an expert in dermatology, having participated in several clinical trials focusing on scalp disorders. Prior to Legacy Healthcare, Dr. Guichard was the manager and founder of the Trichology Unit at Besançon University Hospital (FR)

Marcos Val
CFO
Switzerland
Marcos spent 15 years in Healthcare and FMCG blue-chip corporates. Within biopharma, as Medtronic director, he did launch multi-million revenue programs. He later built a track-record raising funds for startups and carrying due diligence work for impact, until joining Legacy in 2017.

Geert Cauwenbergh ,PhD
Co-Founder & Director
USA
Geert is a co-founder of Legacy Healthcare and a Board member. He is founder and senior managing partner of Phases123, an advisory firm in biotech and healthcare, and serves on the Boards of Genomic Expression and Barcode -Nano. Prior to that he was President & CEO of Phio Pharma, a company he took public, first on the OTC Markets, and later in an upgrade to NASDAQ, and served on the Boards of Cutanea Life Sciences, Phosphagenics, Moberg Pharma, Ogeda, Ablynx, ECI Biotech and BioNJ. Geert was Chairman and CEO of RHEI Pharma and was founder, CEO and Chairman of Barrier Therapeutics, a company he took public on NASDAQ. He served as Vice President of R&D for J&J’s consumer health business and as worldwide director of dermatology and infectious diseases at Janssen. Geert has a M. Sc. And Dr. Med Sc from KU Leuven University in Belgium.

Johanne Barthelet, MBA
Co-Founder & Director
Switzerland
Johanne is co-founder of Legacy Healthcare and serves as a Board member. For 16 years she served as CEO of Tremail, a Swiss-based global freight forwarding and overseas logistics partner for the Swiss premium watch ecosystem with subsidiaries in Europe and Hong Kong, which she sold to a global logistics company. Prior to that she worked for PWC where she focused on transaction services. She served as a consultant for Valtech focused on leveraging technology to maximize branding and positioning. Johanne studied at INSEEC business school in Paris, France.

Peter Nicholson, MBA
Peter serves as an independent Board Member for Legacy Healthcare. He is Managing Director of ALTEKA, a boutique consulting firm focused on strategy and value maximization for the healthcare sector. He served for almost 5 years as Senior Vice President of Global Business Development and General Manager of Dermavant (Organon). For 10 years he led the strategy, business development and alliance management functions for Galderma. He was responsible for business development and investor relations at Mentor (Johnson & Johnson) and held a similar role at INAMED (Allergan). He was co-founder, CEO and board member of Blue Heron Bio (Eurofins Genomics). He transitioned from product development to product licensing at Amgen and was a member of the team that started their corporate venture capital program. Previously, he worked in a number of product development positions early in his career. Peter received his BA in biochemistry, from the University of California at Berkeley and his MBA from UCLA.

Bernard Lignon
Director
Bernard started his career in pharma sales and marketing. He managed the European and African affiliates of several pharmaceutical firms (Sanofi, Akzo, etc.). He has been in charge of the communication of Pierre Fabre, one the largest independent European pharma, and a pioneer of botanical-based treatment and oncology.

Michel Chrétienne PharmD
Director
Michel Chrétienne, PharmD is member of the French Academy of Pharmacy. He spent 30 years as Pharmaceutical Director at Roussel (now Sanofi).

Saad Harti, MBA
Founder, Chairman & CEO
Saad is Chairman and CEO of Legacy Healthcare, a company he founded in 2007. Prior to that he was founder and CEO of Altacare, a distributor of innovative healthcare products servicing 60 markets around the world. He served as Chief Financial Officer of HRA Pharma a fast-growing healthcare company with a focus on women’s health, contraception and compromised skin. He worked as a Director, audit & transactions for Arthur Anderson and began his career in medical marketing as an Assistant Product Manager for Glaxo SmithKline. Saad has an MBA from NEOMA Business School in France.

Nadine Vincent, PharmD
Head of Regulatory Affairs
Nadine leads the regulatory affairs function at Legacy Healthcare beginning in 2013. She spent 16 years HRA Pharma where she was senior manager of international regulatory affairs focused on prescription, orphan and over the counter medications. She has a nearly 30-year career in development and international regulatory affairs for Laboratoire Roussel/Sanofi where she focused on the registration of prescription drugs across therapeutic areas across multiple geographies. Nadine received her doctor pharmacy degree from Universite Paris City and studied the International Management Program at INSEAD.

Vergio - Julien Guiraud, MBA, PhD
Acting as Chief Operating Officer
Vergio is a multidisciplinary firm in life sciences founded by Julien Guiraud.
Julien earned his PhD from the Faculty of Medicine at the University of Amsterdam in 2023. He also holds a Master of Science in Aerospace Engineering from ISAE-SUPAERO (2002) and a Specialized Master in Audit from HEC Paris (2003). Between 2014 and 2021, Julien served as Chief Executive Officer and Chief Scientific Officer at D&A Pharma, where he played a key role in the development of innovative pharmacotherapies. Currently, Julien leads Vergio as its President. Vergio specializes in providing strategic advisory, clinical development, statistical analysis, regulatory affairs, and market access services to pharmaceutical companies. Additionally, Julien is affiliated with the Department of Psychiatry at Amsterdam UMC, University of Amsterdam.
Since November 2024, Vergio has been engaged by Legacy Healthcare to support and manage its operations.

William Pralong, MD, PhD
Chief Scientific Officer
William is Chief Scientific Officer of Legacy Healthcare and Emeritus Professor of the Ecole Polytechnique Fédérale de Lausanne (EPFL) where he held roles of increasing responsibility over his 24-year tenure including Program Director in Life Sciences and Technology. He was a member of the Conseil Suisse d’Accréditation and served as Vice-President of the Ethics Committee for Research on Human Beings for the Canton of Vaud. For three years he was Senior Scientists at Modex Therapeutics. William received his MD. and PhD degrees in pharmacology and biophysics from the University of Geneva where he held posts in the department of internal medicine and in the Institute of Biochemistry

Cécile Bernier
VP Manufacturing Operations & Supply Chain
Cécile is Vice President, Manufacturing Operations and Supply Chain Management and also oversees Quality Compliance at Legacy Healthcare, beginning in 2011. Previously, she was Formulation Manager at Laboratoire PAB and Production Manager at Laboratoires Paris Dome. Cecile received her Chemical Technician diploma from ENCPB Lycée Pierre-Gilles de Gennes and then a Master of Cosmetic Formulation from ISIPCA.

Marco Ruedi, MD
Acting as Chief Medical Officer
Marco serves as acting Chief Medical Officer of Legacy Healthcare and is active in organizations such as Innosuisse, Fongit. FIT, Biopôle and Innovaud where he has worked to support numerous startups in the life sciences sector. He was founder and Chief Medical Officer of Axalbion, a clinical-stage pharmaceutical company. He served a similar role at Alveonix, a company focused on drug development in support of the pharmaceutical industry. He was Managing Director of Aesthetics for Anteis and served in a number of medical/commercial roles over a ten-year period at Sanofi. Marco received his BA in pre-medical training from the University of Fribourg and his MD from the University of Bern.

Jiawei Liu, PhD
Head of Research
Dr. JiaWei Liu’s expertise lies in molecular biology, dermatology, cardiovascular and oncology domains, with over 20 years’ preclinical and clinical research and teaching experience at high ranking academic institutes (Universities and Hospitals Geneva, Lausanne, Harvard Medical School, Shanghai Institute of Materia Medica) and pharmaceutical companies (Debiopharm and Astellas). In addition to numerous peer-reviewed scientific publications, he is the co-inventor of several U.S. and worldwide patents that hold high potential commercial value.

Michel Chrétienne
PharmD
Director of Quality Pharmaceutical Development
France
Michel Chrétienne, PharmD is member of the French Academy of Pharmacy. He spent 30 years as Pharmaceutical Director at Roussel (now Sanofi). He then spent more than 10 years at HRA Pharma, a specialty pharma, as Qualified person in charge of Quality System and batch release.

Chris Cambourg
IT & Technical Director
Switzerland
Around 20 years career in the pharma industry with broad experience in the IT & Technology field. Chris Cambourg is an expert devising and establishing IT policies and systems to support the implementation of strategies set by the company.

Tatiana Rossetti
Director of Clinical Operations
Switzerland
Senior Clinical Development Professional with a 26-year history of working in the pharmaceutical industry. Extensive expertise in strategic planning for new drug development from a Clinical Operational perspective. A proven track record of success in global international programs, working in both contract research organizations (CROs) and biopharmaceutical companies, and achieving successful FDA and EMA drug marketing approvals.

Emmanuel Baert
Country Manager France
France
Emmanuel has almost 25 years of experience in pharmaceutical particularly in rare disease. He managed the operations in France (LFB Biomedicaments , Menarini Hospital for Melinta therapeutics) and launched activities in Latin America (LFB Biomedicaments, Servier). Today, he is Country Manager France, coordinates the European market access and pre-launch..

Tadafumi Shiiba
Country Manager
Japan
Tadafumi Shiiba, General Manager for Legacy Healthcare KK (Japan), has been working for medical corporations for more than 20 years with experiencing to manage two clinical trials on the product in Japan

Ulrike Blume-Peytavi, MD
Principal Investigator
Charité University Berlin, Germany

Junhee Cho, PhD
Principle Investigator
Samsung Medical Center, South Korea

Khalil Zaman, MD, PhD
Principal Investigator
CHUV Lausanne, Switzerland

Bianca Maria Piraccini
Clinical Expert
University of Bologna, Italy

Leorey N. Saligan, PhD, RN
Principal Investigator

NIH Betheda, MD, USA

Yasuyuki Kojima, MD, PhD
Principle Investigator
St Marianna University, Kanagawa, Japan

Kurt Hostettman, PhD
Scientific Advisor, Switzerland

Bruno David, PhD
Scientific Advisor, France